患者对产前使用大麻的看法及其对临床医生的启示
本研究通过18个种族一致性虚拟焦点小组,访谈了53名在产前保健开始时自报使用大麻的孕妇,探讨其使用原因、安全性认知及对医疗体验的期望。参与者平均年龄30.3岁(SD 5.2),入组时平均孕20.9周,69.8%报告每日使用,24.5%每周使用,5.7%每月或更少。许多参与者认为产前使用大麻安全或缺乏科学证据,偏好大麻而非处方药来管理情绪、孕吐、疼痛和睡眠。作者建议产科医生主动开展以患者为中心的对话,建议孕期停用大麻,并探讨转向医学推荐干预措施的意愿。
要点
- 孕妇使用大麻主要为了管理情绪和医学症状,许多人认为比处方药更安全。
- 参与者重视产科医生公开承认其使用动机的对话,并希望获得风险信息。
- 作者建议产科医生主动开展以患者为中心的对话,建议孕期停用大麻,并探讨换用医学推荐干预的意愿。
核心结论
- 孕妇使用大麻来管理情绪和医学症状,许多人认为产前使用大麻比使用处方药更安全。
- 作者认为,产科医生主动发起以患者为中心的关于产前大麻使用的对话、建议孕期停用大麻、并探讨换用医学推荐干预措施治疗妊娠相关症状的意愿,可能使患者受益。
研究设计与样本
- 定性研究,于2021年11月至2021年12月在加利福尼亚州北部一家大型整合医疗系统中,对产前保健开始时自报使用大麻的孕妇开展了18个种族一致性虚拟焦点小组。
- 共纳入53名参与者,其中30名自认为白人,23名自认为黑人;平均年龄30.3岁(SD 5.2岁),入组时平均孕20.9周。
- 焦点小组包含半结构化问题,经录音、转录并由研究团队编码,采用主题分析法分析数据。
主要发现
- 在产前保健开始时,69.8%报告每日使用大麻,24.5%报告每周使用,5.7%报告每月或更少使用。
- 一些参与者因担心潜在健康风险而在早孕期戒断大麻,但许多参与者认为缺乏科学证据或认为产前使用大麻是安全的。
- 许多参与者偏好使用大麻而非非处方药或处方药来治疗情绪、孕吐、疼痛和睡眠。
- 参与者重视与产科医生公开互动并承认其使用动机,希望通过对话和教育材料获得潜在风险信息。
- 白人和黑人参与者的观点总体相似,但少数黑人参与者独特地描述了与产前使用大麻相关的种族偏见担忧。
临床怎么用
- 作者建议产科医生主动发起以患者为中心的关于产前大麻使用的对话。
- 作者建议向患者提供孕期停用大麻的建议。
- 作者建议探讨患者换用医学推荐干预措施治疗妊娠相关症状的意愿。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To understand pregnant patients' reasons for prenatal cannabis use and perceptions of safety, desired and undesirable health care experiences, and desired information about prenatal cannabis use and secondarily to understand racial differences in these perceptions and preferences. METHODS: We conducted a qualitative study including 18 semi-structured, race-concordant virtual focus groups with pregnant individuals who self-reported cannabis use at prenatal care entry in a large integrated health care system in Northern California from November 2021 to December 2021. The focus groups included semi-structured questions that were recorded, transcribed, and coded by the research team. Thematic analysis was used to analyze the data. RESULTS: Overall, 53 participants were included; 30 self-identified, as White and 23 self-identified as Black. Participants averaged 30.3 years of age (SD 5.2 years) and were on average at 20.9 weeks of gestation at study enrollment; 69.8% reported daily cannabis use, 24.5% reported weekly cannabis use, and 5.7% reported monthly or less cannabis use at entrance to prenatal care. Although some participants quit cannabis use in early pregnancy because of concerns about potential health risks, many perceived a lack of scientific evidence or believed that prenatal cannabis use was safe. Many preferred cannabis to over-the-counter or prescription medications for treating mood, morning sickness, pain, and sleep. Participants valued open interactions with obstetricians that acknowledged their motivations for use, and they desired information about potential risks through conversations and educational materials. White and Black participants' perspectives were generally similar, but a few Black participants uniquely described concerns about racial bias related to their prenatal cannabis use. CONCLUSION: Pregnant patients used cannabis to manage mood and medical symptoms, and many believed that prenatal cannabis use was safer than the use of prescription medications. Obstetrician-initiated, patient-centered conversations around prenatal cannabis use, advice to discontinue cannabis use during pregnancy, and exploration of willingness to switch to medically recommended interventions for pregnancy-related symptoms may benefit patients.
引用
- Foti TR, Green A, Altschuler A, et al. Patient Perceptions of Prenatal Cannabis Use and Implications for Clinicians. Obstet Gynecol. 2023. PMID: 37562055. doi:10.1097/AOG.0000000000005295
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。